Home Monitoring of Metabolic Disorders
Home Monitoring of Metabolic Disorders
批准号:
10699781
负责人:
Marylaura Lind Thomas
金额:
$54.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-25 至 2026-08-31
关键词:
AcuteAgeAmmoniaBehaviorBlindedBloodCaregiversCessation of lifeChronicClinicalClinical TrialsCognitionConsensusDataData AnalysesDatabasesDevelopmentDevicesDietDiseaseDropsEmergency department visitEnsureEventFastingFoundationsFrequenciesFundingFutureGeneticGoalsHealthHealth SciencesHereditary DiseaseHomeHome environmentHyperammonemiaImpaired cognitionIndividualInstitutional Review BoardsIntellectual functioning disabilityInterventionKnowledgeLaboratoriesManuscriptsMarketingMeasurementMeasuresMedicalMedical RecordsMedical emergencyMetabolicMetabolic DiseasesMetabolismMonitorMorbidity - disease rateNeurologicNeurologic DysfunctionsNeurologic SymptomsOregonOutcomeParticipantPatient CarePatient RecruitmentsPatientsPerformancePersonsPharmaceutical PreparationsPhysiciansPhysiologyPlasmaPopulationPreventionPreventive measureRecommendationResearchRiskSafetyScienceSignal TransductionSmall Business Innovation Research GrantSurveysSymptomsTarget PopulationsTestingThinkingTimeUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesUrea cycle disordersWorkclinically relevantcohortcommercializationdisabilityeffective therapyexperiencefatty acid oxidationhealth equityhigh riskimprovedinnovationinnovative technologiesinterestmedical attentionmeetingsmembermetermortalityparticipant enrollmentpatient populationpoint of carepreventreal time monitoringrecruitresponsetime use
中文摘要
项目总结
本建议书直接响应NOT-HD-22-009特殊利益通知(NOSI):创新
技术,以改善评估、干预和个人成果
发育障碍[IDD](R43/R44)。患有某些代谢紊乱的所有年龄段的人都有患上
代谢危机当某种代谢物积累时,而这种代谢物可以在临床上测量
实验室,目前还没有基于家庭的设备来监测导致代谢危机的代谢物。
我们团队的长期目标是减少与以下相关的代谢危机的发病率和死亡率
一定的新陈代谢积累。通过之前和正在进行的国家科学基金会和国家科学基金
在卫生研究院小企业创新研究基金的资助下,我们开发了一种家用设备
从一滴血中准确地测量这种代谢物,并正在努力实现FDA的批准。整体而言
这项建议的目的是调查每日以家庭为基础监测目标代谢物的影响
使用我们开发的设备。这将是首次在家中测量代谢物。
以国内的目标人群为衡量标准。
我们的中心假设是,当参与者在家中测量空腹和早晨的代谢物水平时
在获得升高的代谢物结果和患者进一步服用之间存在关联。
采取行动联系他们的医疗团队,进一步监测或采取措施降低代谢物水平。
我们的具体目标是:1)在10名有疾病风险的参与者中进行临床试验
提高代谢物水平,2)分析收集的大量数据,3)准备一份
结果。为了完成我们的方法,我们将从俄勒冈州现有的患者群体中招募患者
健康与科学大学。我们将从参与者的医疗记录、观察、
并对设备进行每日代谢物测量。
这项研究具有创新性,因为它第一次提供了一种直接的、基于家庭的设备
用于测量目标代谢物。在本项目结束时,我们希望更多地了解
居家代谢物监测对病人护理的影响。
英文摘要
PROJECT SUMMARY
This proposal is submitted in direct response to NOT-HD-22-009 Notice of Special Interest (NOSI): Innovative
Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and
Developmental Disabilities [IDD] (R43/R44). Persons of all ages with certain metabolic disorders are at-risk for
metabolic crises when a certain metabolite accumulates, while this metabolite can be measured in a clinical
laboratory, currently there is no home-based device to monitor the metabolie that causes the metabolic crises.
Our team’s long-term goal is to reduce the morbidity and mortality of metabolic crises associated with
certain metabolic accumulation. Through previous and ongoing National Science Foundation and National
Institutes of Health Small Business Innovation Research funding, we have developed an at-home device to
accurately measure this metabolite from a drop of blood and are working towards FDA clearance. The overall
objective of this proposal is to investigate the impact of daily home-based monitoring of the target metabolite
using the device we developed. This will be the first time that at-home measurement of the metabolite will be
measured in the target population at home.
Our central hypothesis is that when participants measure at-home, fasting, morning metabolite levels
there will be an association between getting an elevated metabolite result and then the patient taking further
action to contacting their medical team to further monitor or take steps to reduce the metabolite level.
Our specific aims are 1) to perform a clinical trial in 10 participants with disorders resulting in risk of
elevated metabolite levels, 2) to analyze the extensive data collected, and 3) to prepare a manuscript of the
results. To complete our approach we will recruit patients from the available patient population at Oregon
Health & Science University. We will collect extensive data from the participant medical record, observations,
and the device daily metabolite measurements.
This research is innovative because, for the first time, it provides a straightforward, home-based device
for measurement of the target metabolite. At the conclusion of this project, we expect to understand more the
impact of home-based metabolite monitoring on patient care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Whole Blood Point of Care Metabolic Measurement
-
批准号:10385505
-
项目类别:
-
资助金额:$63.78万
-
财政年份:2021
-
负责人:Marylaura Lind Thomas
-
依托单位:
Whole Blood Point of Care Metabolic Measurement
-
批准号:10618091
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2021
-
负责人:Marylaura Lind Thomas
-
依托单位:
Whole Blood Point of Care Metabolic Measurement
-
批准号:10490896
-
项目类别:
-
资助金额:$63.37万
-
财政年份:2021
-
负责人:Marylaura Lind Thomas
-
依托单位:
Whole Blood Point of Care Metabolic Measurement
-
批准号:10909646
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2021
-
负责人:Marylaura Lind Thomas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: